Kainos Medicine, Inc. (KOSDAQ:284620)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Pharmaceuticals	267.31M	130.02M	-
Pharmaceuticals Growth	105.59%	-	-
Total	267.31M	130.02M	-
Total Growth	105.59%	-	-

Revenue by Geography

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
China	267.31M	130.02M	-
China Growth	105.59%	-	-
Total	267.31M	130.02M	-
Total Growth	105.59%	-	-

Source: S&P Global Market Intelligence.